SPONSOR
Jiping Wang, MD, PhD
Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Resectable Hepatocellular CarcinomaHepatocellular CarcinomaHepatocellular Cancer
Clinical Trials by Jiping Wang, MD, PhD
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology